Science Explorer Back to mapMap
Discussion
Researcher · University Hospital Olomouc · Czechia

Radovan Uvízl

Radovan Uvízl publishes mostly in Critical Care and Intensive Care Medicine, Epidemiology and Pulmonary and Respiratory Medicine, on topics such as Nosocomial Infections in ICU, Pneumonia and Respiratory Infections and Antibiotic Resistance in Bacteria.

OpenAlex
World rank
#6,169,962
of 7,710,434 ranked researchers
Rank in Czechia
#25,126
of 39,303
Works
21
Citations
215
Citations per work
10.2
h-index
8
i10-index 8Top 71% in Critical Care and Intensive Care Medicine
Radovan Uvízl

What does Radovan Uvízl research?

Radovan Uvízl's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (9%), Immunology and Microbiology (4%).

Health Sciences: 12 works · 56.1% of their workMedicine: 12 works · 56.1% of their workCritical Care and Intensive Care Medicine: 6 works · 26.3% of their workEpidemiology: 4 works · 17.5% of their workPulmonary and Respiratory Medicine: 2 works · 8.8% of their workInfectious Diseases: 1 works · 3.5% of their workEverything else: 7 works · 31.6% of their workLife Sciences: 3 works · 12.3% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 8.8% of their workMolecular Medicine: 2 works · 8.8% of their workImmunology and Microbiology: 1 works · 3.5% of their workApplied Microbiology and Biotechnology: 1 works · 3.5% of their workTHEIR WORKRadovan Uvízl21works
Life Sciences12%Health Sciences56%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1256.1%
  2. Everything else731.6%
    1. Biochemistry, Genetics and Molecular Biology28.8%
    2. Immunology and Microbiology13.5%
  1. 1Critical Care and Intensive Care Medicine26% of their works
  2. 2Epidemiology18% of their works
  3. 3Pulmonary and Respiratory Medicine9% of their works
  4. 4Molecular Medicine9% of their works
  5. 5Infectious Diseases4% of their works
  6. 6Applied Microbiology and Biotechnology4% of their works

Research topics

Which keywords describe Radovan Uvízl's research?

The keywords of their largest research topics: Epidemiology, ICU, Ventilator-associated Pneumonia, Antibiotic Resistance, Community-Acquired Pneumonia, Pneumococcal Conjugate Vaccine, ESKAPE Pathogens and Multidrug-Resistant Bacteria.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Epidemiology123 topics
  2. ICU121 topic
  3. Ventilator-associated Pneumonia121 topic
  4. Antibiotic Resistance72 topics
  5. Community-Acquired Pneumonia61 topic
  6. Pneumococcal Conjugate Vaccine61 topic
  7. ESKAPE Pathogens51 topic
  8. Multidrug-Resistant Bacteria51 topic
  9. Sepsis41 topic
  10. Septic Shock41 topic
  11. Acute Lung Injury21 topic
  12. Antimicrobial Stewardship21 topic
  13. Delirium21 topic
  14. Global Health21 topic
  15. Intensive Care Unit21 topic
  16. Mechanical Ventilation21 topic
  17. Genomics11 topic
  18. Plant Pathogenic Bacteria11 topic

Where does Radovan Uvízl work?

Radovan Uvízl's main affiliation in the publication record is University Hospital Olomouc, Czechia.

How many publications and citations does Radovan Uvízl have?

OpenAlex counts 21 works and 215 citations for Radovan Uvízl, an h-index of 8, ranking #6,169,962 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Radovan Uvízl. Posts are plain text and can be reported.